Tag: EHRA 2021
EHRA 2021: Subcutaneous ICDs maintain cardioversion efficacy of 98% across five-year...
Subcutaneous implantable cardioverter defibrillator (S-ICD) devices have demonstrated a cardioversion efficacy rate of 98% over a period of at least five years in the...
EHRA 2021: Efforts should be made to increase participation in atrial...
Further efforts should be made to increase participation in atrial fibrillation (AF) screening—particularly in elderly populations, where systematic screening for AF can help to...
EHRA 2021: Study advocates screening ICD patients for depression and anxiety
Patients receiving an implantable cardioverter defibrillator (ICD) should be regularly screened for anxiety and depression, according to research presented at the European Heart Rhythm...
EHRA 2021: Diabetic patients could be screened for AF during foot...
Atrial fibrillation (AF) could be detected during annual foot assessments in patients with diabetes, according to research presented today at the European Heart Rhythm...